Prohost Letter #393
IMMUNOTHERAPY - PROHOST PORTFOLIO - NEW PICKS? - A Brief Reminder of the CAR T –TCR Immunotherapy Approaches In this issue we continue our journey inside the territory of cancer immunotherapy. We remind that in the Prohost Letter issue #391, we dealt with the immunotherapy based on genetically engineered T Cells, enabling them to seek out, attack and neutralize cancer cells.
The immune system’s T cells’ task is to rid the body of foreign invaders and other diseases. Yet, for reasons just beginning to be enumerated, these cells have fallen short of doing . . .